Patients with OSA demonstrate marked systemic inflammatory responses, characterized by elevated levels of pro-inflammatory substances, including C-reactive protein, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), alongside diminished levels of the anti-inflammatory marker IL-10 (12, 13). The gene discussed is IL6; the disease is obstructive sleep apnea syndrome.